{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T05:03:19Z","timestamp":1785560599554,"version":"3.56.0"},"reference-count":37,"publisher":"Elsevier BV","issue":"43","license":[{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1016\/j.vaccine.2018.08.087","type":"journal-article","created":{"date-parts":[[2018,9,12]],"date-time":"2018-09-12T12:52:43Z","timestamp":1536756763000},"page":"6433-6441","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":40,"title":["Randomized, controlled, double-blinded field trial to assess Leishmania vaccine effectiveness as immunotherapy for canine leishmaniosis"],"prefix":"10.1016","volume":"36","author":[{"given":"Angela","family":"Toepp","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mandy","family":"Larson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geneva","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tara","family":"Grinnage-Pulley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolyne","family":"Bennett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Leal-Lima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bryan","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Molly","family":"Parrish","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hailie","family":"Fowler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Hinman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Kontowicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane","family":"Jefferies","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marvin","family":"Beeman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesse","family":"Buch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jill","family":"Saucier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phyllis","family":"Tyrrell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Radhika","family":"Gharpure","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caitlin","family":"Cotter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Petersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2018.08.087_b0005","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1093\/trstmh\/trv039","article-title":"Development of Leishmania vaccines in the era of visceral leishmaniasis elimination","volume":"109","author":"Engwerda","year":"2015","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2018.08.087_b0010","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/j.pt.2017.05.005","article-title":"Novel areas for prevention and control of canine leishmaniosis","volume":"33","author":"Miro","year":"2017","journal-title":"Trends Parasitol"},{"key":"10.1016\/j.vaccine.2018.08.087_b0015","doi-asserted-by":"crossref","first-page":"e393","DOI":"10.1016\/S1473-3099(17)30442-5","article-title":"Immunotherapeutic approaches to treatment of fungal diseases","volume":"17","author":"Armstrong-James","year":"2017","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2018.08.087_b0020","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.curtheres.2017.04.006","article-title":"Clinical evaluation of terap c vaccine in combined treatment with interferon and ribavirin in patients with hepatitis C","volume":"85","author":"Zaily","year":"2017","journal-title":"Curr Therap Res, Clin Experiment"},{"key":"10.1016\/j.vaccine.2018.08.087_b0025","doi-asserted-by":"crossref","first-page":"e35671","DOI":"10.1371\/journal.pone.0035671","article-title":"Leishmaniasis worldwide and global estimates of its incidence","volume":"7","author":"Alvar","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2018.08.087_b0030","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1038\/nrmicro2608","article-title":"Leishmaniasis: complexity at the host-pathogen interface","volume":"9","author":"Kaye","year":"2011","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.vaccine.2018.08.087_b0035","doi-asserted-by":"crossref","first-page":"4100","DOI":"10.4049\/jimmunol.1502678","article-title":"Regulatory IgDhi B cells suppress T cell function via IL-10 and PD-L1 during progressive visceral leishmaniasis","volume":"196","author":"Schaut","year":"2016","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2018.08.087_b0040","doi-asserted-by":"crossref","first-page":"5542","DOI":"10.4049\/jimmunol.1301810","article-title":"Programmed death 1-mediated T cell exhaustion during visceral leishmaniasis impairs phagocyte function","volume":"191","author":"Esch","year":"2013","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2018.08.087_b0045","doi-asserted-by":"crossref","first-page":"B244","DOI":"10.1016\/j.vaccine.2012.11.080","article-title":"Case study for a vaccine against leishmaniasis","volume":"31","author":"Alvar","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.08.087_b0050","doi-asserted-by":"crossref","first-page":"125","DOI":"10.4269\/ajtmh.1996.55.125","article-title":"The logic of visceral leishmaniasis control","volume":"55","author":"Dye","year":"1996","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2018.08.087_b0055","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aac5477","article-title":"Identification of broadly conserved cross-species protective Leishmania antigen and its responding CD4+ T cells","volume":"7","author":"Mou","year":"2015","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.vaccine.2018.08.087_b0060","doi-asserted-by":"crossref","first-page":"2234","DOI":"10.1016\/j.vaccine.2003.11.039","article-title":"Effective immunotherapy against canine visceral leishmaniasis with the FML-vaccine","volume":"22","author":"Borja-Cabrera","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.08.087_b0065","doi-asserted-by":"crossref","first-page":"217","DOI":"10.3389\/fimmu.2017.00217","article-title":"A vaccine therapy for canine visceral leishmaniasis promoted significant improvement of clinical and immune status with reduction in parasite burden","volume":"8","author":"Roatt","year":"2017","journal-title":"Front Immunol"},{"key":"10.1016\/j.vaccine.2018.08.087_b0070","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/j.pt.2017.06.004","article-title":"Diagnostic challenges in the era of canine leishmania infantum vaccines","volume":"33","author":"Solano-Gallego","year":"2017","journal-title":"Trends Parasitol"},{"key":"10.1016\/j.vaccine.2018.08.087_b0075","doi-asserted-by":"crossref","first-page":"e1019","DOI":"10.1371\/journal.pntd.0001019","article-title":"Transplacental transmission of Leishmania infantum as a means for continued disease incidence in North America","volume":"5","author":"Boggiatto","year":"2011","journal-title":"PLoS Negl Trop Dis."},{"key":"10.1016\/j.vaccine.2018.08.087_b0080","doi-asserted-by":"crossref","first-page":"e1005302","DOI":"10.1371\/journal.ppat.1005302","article-title":"A mother's gift: congenital transmission of trypanosoma and leishmania species","volume":"12","author":"Grinnage-Pulley","year":"2016","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.vaccine.2018.08.087_b0085","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.vetimm.2015.11.008","article-title":"Immunologic progression of canine leishmaniosis following vertical transmission in United States dogs","volume":"169","author":"Vida","year":"2016","journal-title":"Vet Immunol Immunopathol"},{"key":"10.1016\/j.vaccine.2018.08.087_b0090","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1038\/nrmicro1748","article-title":"Visceral leishmaniasis: what are the needs for diagnosis, treatment and control?","volume":"5","author":"Chappuis","year":"2007","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.vaccine.2018.08.087_b0095","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.it.2007.07.004","article-title":"Interleukin-10 and the pathogenesis of human visceral leishmaniasis","volume":"28","author":"Nylen","year":"2007","journal-title":"Trends Immunol"},{"key":"10.1016\/j.vaccine.2018.08.087_b0100","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1093\/infdis\/jir461","article-title":"IL-10 neutralization promotes parasite clearance in splenic aspirate cells from patients with visceral leishmaniasis","volume":"204","author":"Gautam","year":"2011","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2018.08.087_b0105","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1093\/infdis\/jit401","article-title":"CD8 T cell exhaustion in human visceral leishmaniasis","volume":"209","author":"Gautam","year":"2014","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2018.08.087_b0110","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.3389\/fimmu.2017.01492","article-title":"Immune checkpoint targets for host-directed therapy to prevent and treat leishmaniasis","volume":"8","author":"Kumar","year":"2017","journal-title":"Front Immunol"},{"key":"10.1016\/j.vaccine.2018.08.087_b0115","doi-asserted-by":"crossref","first-page":"5225","DOI":"10.1016\/j.vaccine.2016.09.016","article-title":"Recovery of antigen-specific T cell responses from dogs infected with Leishmania (L.) infantum by use of vaccine associated TLR-agonist adjuvant","volume":"34","author":"Schaut","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.08.087_b0120","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1016\/j.vaccine.2016.03.019","article-title":"Field randomized trial to evaluate the efficacy of the Leish-Tec((R)) vaccine against canine visceral leishmaniasis in an endemic area of Brazil","volume":"34","author":"Regina-Silva","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.08.087_b0125","first-page":"7","article-title":"Performance of SNAP (R) 4Dx (R) plus and accuplex (TM) 4 in dogs with different heartworm burdens","volume":"11","author":"Eberts","year":"2013","journal-title":"Int J Appl Res Vet M"},{"key":"10.1016\/j.vaccine.2018.08.087_b0130","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1007\/s00253-016-7925-6","article-title":"Semi-quantitative measurement of asymptomatic L. infantum infection and symptomatic visceral leishmaniasis in dogs using Dual-Path Platform(R) CVL","volume":"101","author":"Larson","year":"2017","journal-title":"Appl Microbiol Biotechnol"},{"key":"10.1016\/j.vaccine.2018.08.087_b0135","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/1756-3305-4-86","article-title":"LeishVet guidelines for the practical management of canine leishmaniosis","volume":"4","author":"Solano-Gallego","year":"2011","journal-title":"Parasit Vectors"},{"key":"10.1016\/j.vaccine.2018.08.087_b0140","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1016\/0140-6736(92)91255-7","article-title":"Prevalence of Leishmania infection among AIDS patients","volume":"339","author":"Alvar","year":"1992","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2018.08.087_b0145","first-page":"75","article-title":"Leishmania incidence and prevalence in U.S. hunting hounds maintained via vertical transmission","volume":"10","author":"Toepp","year":"2017","journal-title":"Veterinary Parasitol: Regional Studies Reports"},{"key":"10.1016\/j.vaccine.2018.08.087_b0150","doi-asserted-by":"crossref","first-page":"2298","DOI":"10.1016\/j.vaccine.2003.11.023","article-title":"Moderate exercise improves antibody response to influenza immunization in older adults","volume":"22","author":"Kohut","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.08.087_b0155","doi-asserted-by":"crossref","DOI":"10.4269\/ajtmh.17-0888","article-title":"Safety analysis of leishmania vaccine used in a randomized canine vaccine\/immunotherapy trial","author":"Toepp","year":"2018","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2018.08.087_b0160","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.vetpar.2011.05.009","article-title":"Evaluation of miltefosine for the treatment of dogs naturally infected with L. infantum (=L. chagasi) in Brazil","volume":"181","author":"Andrade","year":"2011","journal-title":"Vet Parasitol"},{"key":"10.1016\/j.vaccine.2018.08.087_b0165","doi-asserted-by":"crossref","first-page":"e0004896","DOI":"10.1371\/journal.pntd.0004896","article-title":"Transmission dynamics of visceral leishmaniasis in the Indian subcontinent \u2013 a systematic literature review","volume":"10","author":"Hirve","year":"2016","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.vaccine.2018.08.087_b0170","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1086\/344312","article-title":"Infectiousness in a cohort of Brazilian dogs: Why culling fails to control visceral leishmaniasis in areas of high transmission","volume":"186","author":"Courtenay","year":"2002","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2018.08.087_b0175","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/1756-3305-4-52","article-title":"Infectivity to Phlebotomus perniciosus of dogs naturally parasitized with Leishmania infantum after different treatments","volume":"4","author":"Miro","year":"2011","journal-title":"Parasit Vectors"},{"key":"10.1016\/j.vaccine.2018.08.087_b0180","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.vetpar.2008.10.097","article-title":"Distinct antigen recognition pattern during zoonotic visceral leishmaniasis in humans and dogs","volume":"160","author":"Goto","year":"2009","journal-title":"Vet Parasitol"},{"key":"10.1016\/j.vaccine.2018.08.087_b0185","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1038\/nm1592","article-title":"Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania major","volume":"13","author":"Darrah","year":"2007","journal-title":"Nat Med"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X18312453?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X18312453?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:28:07Z","timestamp":1759400887000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X18312453"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":37,"journal-issue":{"issue":"43","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["S0264410X18312453"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2018.08.087","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Randomized, controlled, double-blinded field trial to assess Leishmania vaccine effectiveness as immunotherapy for canine leishmaniosis","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2018.08.087","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}